

<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:slash="http://purl.org/rss/1.0/modules/slash/">

    <channel>
        <title>PharmiWeb.com Articles</title>
        <atom:link href="https://www.pharmiweb.com/rss/articles" rel="self" type="application/rss+xml" />
        <link>https://www.pharmiweb.com</link>
        <description>PharmiWeb.com | Articles in the Pharmaceutical industry</description>
        <lastBuildDate>Fri, 13 Mar 2026 07:43:20 +00:00</lastBuildDate>
        <language>en-GB</language>
        <sy:updatePeriod>hourly</sy:updatePeriod>
        <sy:updateFrequency>1</sy:updateFrequency>
                <item>
                    <title>Why Safety Data Overload Is the Next Big Pharmacovigilance Challenge</title>
                    <link>https://www.pharmiweb.com/article/why-safety-data-overload-is-the-next-big-pharmacovigilance-challenge</link>
                    <pubDate>Fri, 06 Mar 2026 05:56:51 +00:00</pubDate>
                    <guid isPermaLink="false">229721</guid>
                    <description><![CDATA[What Is Safety Data Overload in Pharmacovigilance?
Safety data overload in pharmacovigilance refers to the situation where drug‑safety teams are inundated with an ever‑increasing volume of individual case safety reports (ICSRs), literature cases, social‑media mentions, and other safety‑related data, far beyond their capacity to review, assess, and act on each item in a timely and meaningful way. This deluge arises from multiple reporting channels (spontaneous reports, clinical trials, electro...]]></description>
                </item>
                <item>
                    <title>Digital Pharmaceutical Supply Chain Management Market Size, Share &amp; Growth Analysis</title>
                    <link>https://www.pharmiweb.com/article/digital-pharmaceutical-supply-chain-management-market-size-share-growth-analysis</link>
                    <pubDate>Fri, 06 Mar 2026 05:53:30 +00:00</pubDate>
                    <guid isPermaLink="false">229720</guid>
                    <description><![CDATA[Market Overview
The digital pharmaceutical supply chain management market is projected to expand at a compound annual growth rate (CAGR) of approximately 9% between 2025 and 2030, reflecting the growing transition toward technology-driven supply chain ecosystems in the pharmaceutical industry. As pharmaceutical supply networks become more complex and globalized, organizations are increasingly adopting digital technologies to improve visibility, efficiency, and operational resilience.
Pharmace...]]></description>
                </item>
                <item>
                    <title>AI-Augmented MSPs and the Remote Monitoring Workforce</title>
                    <link>https://www.pharmiweb.com/article/ai-augmented-msps-and-the-remote-monitoring-workforce</link>
                    <pubDate>Tue, 10 Mar 2026 04:31:31 +00:00</pubDate>
                    <guid isPermaLink="false">229939</guid>
                    <description><![CDATA[Summary: Workplace attrition threatens operational continuity and clinical trial timelines for life science professionals. The recent shift to remote and decentralized trials presents unique challenges. Fueled by systemic issues like burnout and depersonalization, and the unique pressures of data-intensive remote work, traditional retention strategies are failing.
AI-augmented managed service providers (MSPs) offer a predictive alternative that transforms retention into proactive strategies....]]></description>
                </item>
                <item>
                    <title>A Comprehensive Guide to Clinical Trial Supply Management and Operations</title>
                    <link>https://www.pharmiweb.com/article/a-comprehensive-guide-to-clinical-trial-supply-management-and-operations</link>
                    <pubDate>Fri, 20 Feb 2026 09:14:36 +00:00</pubDate>
                    <guid isPermaLink="false">228669</guid>
                    <description><![CDATA[

Clinical trial supply management is the backbone of successful clinical research, ensuring that investigational products reach study sites on time, in optimal condition, and in compliance with global regulations. Effective clinical trial supply chain management ensures trials run smoothly, safeguards patient safety, and preserves the integrity of clinical data.
Modern clinical trials, including decentralized designs, global studies, and personalized therapies, demand a deep understanding of...]]></description>
                </item>
                <item>
                    <title>The Critical Role of Audits in Ensuring Compliance: A Comprehensive Guide</title>
                    <link>https://www.pharmiweb.com/article/the-critical-role-of-audits-in-ensuring-compliance-a-comprehensive-guide</link>
                    <pubDate>Fri, 13 Feb 2026 02:11:13 +00:00</pubDate>
                    <guid isPermaLink="false">228267</guid>
                    <description><![CDATA[Introduction to Audits
In the fields of pharmaceuticals and medical devices where regulation is imposed, compliance with the quality standards set by the authorities is vital for the protection of the products from dangerous effects and ensuring therapeutic efficiency. Audits form an integral part, used to gauge the compliance of an organization with the regulations of these authorities. They may be held internally, by vendors, or by regulatory bodies such as the FDA.
The audits&#39; main functio...]]></description>
                </item>
                <item>
                    <title>Joint Clinical Assessment (JCA) Update — What It Is and What’s Changing</title>
                    <link>https://www.pharmiweb.com/article/joint-clinical-assessment-jca-update-what-it-is-and-what-s-changing</link>
                    <pubDate>Wed, 25 Feb 2026 04:10:38 +00:00</pubDate>
                    <guid isPermaLink="false">229048</guid>
                    <description><![CDATA[The introduction of Joint Clinical Assessment JCA marks one of the most significant regulatory and market access changes in the European pharmaceutical landscape in decades. Established under the European Health Technology Assessment Regulation Regulation 2021 2282, JCA is reshaping how clinical evidence is assessed across EU member states.

For professionals working in regulatory affairs, market access, HEOR, clinical development, or medical affairs, understanding JCA is now essential. Below...]]></description>
                </item>
                <item>
                    <title>Pharmaceutical Sales in the UK: A Structural Shift in Talent and Training</title>
                    <link>https://www.pharmiweb.com/article/pharmaceutical-sales-in-the-uk-a-structural-shift-in-talent-and-training</link>
                    <pubDate>Tue, 24 Feb 2026 05:14:19 +00:00</pubDate>
                    <guid isPermaLink="false">228938</guid>
                    <description><![CDATA[Pharmaceutical sales in the UK are undergoing a gradual but meaningful shift in who represents medicines to healthcare professionals. Increasingly, companies are recruiting sales representatives without traditional medical or scientific backgrounds. This evolution, driven in part by changing commercial models and the growth of Contract Sales Organisations (CSOs) - reflects broader expansion across the UK and European pharmaceutical outsourcing market.&#178; &#179; ⁷
A Strategic Shift Towards Non-Medica...]]></description>
                </item>
                <item>
                    <title>Procurement as Strategic Business Enabler: How Alkermes Unlocked $30M in Project Cost Savings</title>
                    <link>https://www.pharmiweb.com/article/procurement-as-strategic-business-enabler-how-alkermes-unlocked-30m-in-project-cost-savings-with-jaggaer</link>
                    <pubDate>Tue, 24 Feb 2026 11:49:59 +00:00</pubDate>
                    <guid isPermaLink="false">228881</guid>
                    <description><![CDATA[Alkermes is a fully integrated biopharmaceutical company headquartered in Dublin, Ireland, with R&amp;amp;D and manufacturing facilities in the U.S. With $1.5B in annual revenue, Alkermes has focused for more than 30 years on developing innovative treatments for psychiatric and neurological disorders. At a time when 40% of procurement teams said manual and inefficient processes are holding them back[1], the company turned to JAGGAER to improve spend visibility and create standardized workflows ac...]]></description>
                </item>
                <item>
                    <title>From Passive Endpoints to Engineered Outcomes: The Clinical Case for Resilience in Oncology</title>
                    <link>https://www.pharmiweb.com/article/from-passive-endpoints-to-engineered-outcomes-the-clinical-case-for-resilience-in-oncology</link>
                    <pubDate>Tue, 24 Feb 2026 10:51:04 +00:00</pubDate>
                    <guid isPermaLink="false">228869</guid>
                    <description><![CDATA[The integration of artificial intelligence and advanced computational modeling has already catalyzed a structural shift in global healthcare. In oncology, this &quot;Precision Medicine&quot; era has successfully moved the needle on early diagnostics and molecularly targeted therapies. However, while we have become experts at targeting the tumor, we are only just beginning to understand the host’s capacity for survival.
The next evolution in cancer care will not be defined solely by the discovery of new...]]></description>
                </item>
                <item>
                    <title>Clinical Data Review and Analysis: Key Insights for Pharma Professionals</title>
                    <link>https://www.pharmiweb.com/article/clinical-data-review-and-analysis-key-insights-for-pharma-professionals</link>
                    <pubDate>Tue, 24 Feb 2026 09:39:27 +00:00</pubDate>
                    <guid isPermaLink="false">228859</guid>
                    <description><![CDATA[Clinical data review and analysis is a cornerstone of modern pharmaceutical research and development. With the growing complexity of clinical trials and regulatory requirements, accurate and efficient data management has never been more critical. Understanding the process from raw data collection to final analysis ensures that clinical findings are reliable, actionable, and compliant with global standards.
At its core, clinical data review involves the systematic examination of trial data for...]]></description>
                </item>
                <item>
                    <title>What are the biggest recruitment fraud risks in 2026?</title>
                    <link>https://www.pharmiweb.com/article/what-are-the-biggest-recruitment-fraud-risks-in-2026</link>
                    <pubDate>Thu, 12 Feb 2026 10:15:44 +00:00</pubDate>
                    <guid isPermaLink="false">228180</guid>
                    <description><![CDATA[The biggest recruitment fraud risks in 2026 are primarily driven by the&amp;nbsp;democratisation and sophistication of Generative AI, which has transformed traditional &quot;resume embellishment&quot; into a systemic crisis of identity and qualification verification,.
The following are the primary recruitment fraud risks identified for 2026:
1. AI-Powered Identity Deception (Deepfakes and Voice Cloning)
One of the most concerning trends is the rise of&amp;nbsp;real-time deepfake video and audio&amp;nbsp;during vir...]]></description>
                </item>
                <item>
                    <title>Pharmaceutical Technology Excellence Awards 2025: ACTO</title>
                    <link>https://www.pharmiweb.com/article/pharmaceutical-technology-excellence-awards-2025-acto</link>
                    <pubDate>Thu, 12 Feb 2026 05:33:38 +00:00</pubDate>
                    <guid isPermaLink="false">228218</guid>
                    <description><![CDATA[ACTO’s CxZone won the Innovation award in the AI Roleplay category for its targeted use of AI roleplay to address persistent challenges in pharmaceutical field engagement. One of the most significant hurdles for pharmaceutical companies is ensuring that the strategies developed at headquarters translate effectively into field conversations with HCPs—especially when access to these providers is limited and the pressure to deliver concise, clinically relevant information is high. ACTO developed...]]></description>
                </item>
    </channel>
</rss>